logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

William A Haseltine

This inventor holds 25 USPTO granted patents, primarily in HIV Research. Top assignees: Dana-Farber-Cancer Institute Inc., Behringwerke Aktiengesellschaft, Cambridge Bioscience Corporation. Active years: 1988-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William A Haseltine. Retrieved from https://idiyas.com/inventor/william-a-haseltine-jpopkol0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 25

% Patents Active = 100.0

Average Co-Inventor Count = 3.1

ph-index = 12

Forward Citations = 479(Granted Patents)


Location History:

  • Rockville, MD (US) (1998)
  • Canbridge, MA (US) (1998)
  • Boston, MA (US) (1999)
  • Cambridge, MA (US) (1988 - 2001)

Company Filing History:

goldMedal24 out of 1,269 
 
Dana-Farber-Cancer Institute Inc.
 patents
silverMedal1 out of 340 
 
Behringwerke Aktiengesellschaft
 patents
bronzeMedal1 out of 6 
 
Cambridge Bioscience Corporation
 patents
4. 1 out of 2,560 
 
Columbia University
 patents
5. 1 out of 53 
 
New England Deaconess Hospital Corporation
 patents
6. 1 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
where one patent can have more than one assignee

Years Active: 1988-2001

Loading Chart...
Areas of Expertise:
Intracellular Binding
HIV Vectors
Immunogenic Peptides
Antibodies
Tat Protein
Gene Expression
DNA Sequencing
Transcriptional Factors
Recombinant Antibodies
Cell Line Assays
Neutralizing Antibodies
Cis-acting Sequences
25 patents (USPTO):Explore Patents
1. 6329173 - Method of intracellular binding target molecules (2001-12-11),
2. 6072036 - Method of intracellular binding of target molecules (2000-06-06),
3. 6033902 - Vector comprising a replication competent HIV-1 provirus and a (2000-03-07),
4. 5981276 - Vectors containing HIV packaging sequences, packaging defective HIV (1999-11-09),
5. 5965371 - Method of intracellular binding of target molecules (1999-10-12),
6. 5858366 - Immunogenic peptides, antibodies and uses thereof relating to CD4 (1999-01-12),
7. 5852186 - Reactive neutralizing human anti-GP120 recombinant antibody, DNA coding (1998-12-22),
8. 5851829 - Method of intracellular binding of target molecules (1998-12-22),
9. 5817316 - Immunogenic peptides, antibodies and uses thereof relating to CD4 (1998-10-06),
10. 5801056 - Nucleic acid encoding HIV-1 tat protein (1998-09-01),
11. 5800986 - Assay methods for tat cell lines (1998-09-01),
12. 5759768 - Assays for factors affecting circularization of DNA, assays for factors (1998-06-02),
13. 5665577 - Vectors containing HIV packaging sequences, packaging defective HIV (1997-09-09),
14. 5654195 - Vectors expressing hybrid viruses, methods of use and novel assays (1997-08-05),
15. 5652144 - YC1 gene (1997-07-29),

Title: William A Haseltine: Pioneering Inventor from Cambridge, MA

Introduction: William A Haseltine is a renowned inventor based in Cambridge, MA, known for his groundbreaking contributions to the field of science and technology.

Latest Patents: William A Haseltine holds several patents in the areas of biotechnology, healthcare, and pharmaceuticals, showcasing his innovative spirit and commitment to advancing these industries.

Career Highlights: With a distinguished career spanning several decades, William A Haseltine has founded multiple successful biotechnology companies and has been at the forefront of cutting-edge research and development in the life sciences sector.

Collaborations: Throughout his career, William A Haseltine has collaborated with leading researchers, scientists, and institutions globally, fostering a culture of innovation and knowledge-sharing in the scientific community.

Conclusion: William A Haseltine's passion for innovation and his relentless pursuit of scientific excellence have solidified his reputation as a trailblazing inventor in the field of biotechnology and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…